Putting Patients First
|
|
46-year-old
Stephen Sprague never thought that he would be diagnosed with leukemia
at that age, a deadly clandestine blood disease with very few symptoms
and one often believed to be found mainly in children. Despite his
unfortunate diagnosis, Stephen was determined to fight the leukemia. But
after 17 months of treatments, he found himself facing the deadly
end-stage of the disease much sooner than many patients who have four to
five years before reaching that point. Deciding to pursue bone marrow
transplant, Stephen knew his chances were slim. As an only child, he had
no near relatives to look to for matching bone marrow. Trying to match
unrelated bone marrow was unlikely and, as expected, it turned out
unsuccessful. Stephen considers what happened next to be nothing short
of a medical miracle.
Stephen’s oncologist was in the process of beginning a clinical-trial
for leukemia patients where doctors would match stem cells derived from
umbilical cord blood and use them to successfully treat end-stage adult
leukemia patients. Almost instantly, Stephen’s perfect cord blood match
was found in the New York Blood Center, the oldest cord blood bank in
the United States. The donor—a young mother who, years ago, decided to
donate her baby’s umbilical cord to the bank, perhaps in the hope that
someday it would mean a chance at life for someone else. The young
mother was right.
Stephen’s transplant, using adult stem cells from an umbilical cord, was
successful. Now ten years later, Stephen stood before me telling his
story this week in the Committee on Science and Technology hearing
room—completely cancer free.
There are stories like Stephen’s scattered across the nation. Adults
treated and cured of their diseases by adult stem cells. U.S. doctor
Amid Patel has used adult stem cells to successfully treat over 1,800
patients who suffered from severe heart failure, dramatically increasing
their qualities of life and chances of survival. Dr. Patel says the most
amazing thing about performing this of type treatment is that it allows
his patients to return to their normal lives as they were before they
suffered heart failure. Adult stem cells have even cured patients of
their Type 1 Diabetes.
Unfortunately, medical breakthrough stories like Stephen’s and Dr.
Patel’s are often clouded by an ongoing and heated ethical debate over
embryonic stem cell research, which uses stem cells derived from human
embryos. While we must devote enormous energy to conquering disease, it
is equally important that we pay attention to the moral concerns raised
by human embryonic stem cell research.
Proponents
of embryonic stem cell research argue that embryonic stem cell
treatments may be successful in 20 or 30 years. But adult stem cells are
treating people now. There are real life stories of people, like
Stephen Sprague, who are being cured of their life-altering diseases as
a result of adult stem cells. So why is there such a huge push to fund
embryonic stem cell research, when its success could be decades away?
Why are we not putting patients first by focusing our research funding
on the type of stem cell treatment that has proven results today? Why
are we not hearing more success stories like Stephen’s?
Just this week, in a bipartisan press conference joined by patients who
have been successfully treated with adult stem cells therapies, I
introduced the Patients First Act,
H.R. 2807.
The Patients First Act will prioritize our stem cell research efforts
towards those that are providing the greatest potential to patients
right now. The bill would provide funding for all stem cell research so
long as human embryos are not destroyed. Additionally, the Patients
First Act directs the National Institutes of Health to prioritize
research that can treat people in the near term, and calls for an annual
report on all stem cell research grants that are not funded, with an
explanation as to why they were not funded.
Rarely do we, as citizens and public servants, have the opportunity to
make a decision with the potential to truly alter our nation’s future.
The issue of embryonic stem cell research has become divisive, and when
there are cures and human lives at stake, divisiveness is not a luxury
that we have. The Patients First Act bridges the political divide and
focuses our energies on the common goal shared by both sides of the
embryonic stem cell debate - curing and treating patients. |
|
|
SPOTLIGHT
The Capitol Monitor Has a New Look!
The Capitol Monitor has taken
on a new look! We would love to hear your feedback on the new design. We
welcome your thoughts, comments, and suggestions.
Click here to
send an email.
Congressman Forbes' Summer Primer Series Kicks Off
![](https://webarchive.library.unt.edu/web/20121110140112im_/http://forbes.house.gov/UploadedPhotos/thumbnails/8a0cf903-ab93-4c50-b329-579cc17be6b9.jpg)
Congressman Forbes will release four primers this summer on important
issues impacting you like energy prices, health care, and immigration.
Click here to
go to the Summer Primer Series page.
Deadline Approaching for Relaxed Passport Laws
![](https://webarchive.library.unt.edu/web/20121110140112im_/http://forbes.house.gov/UploadedPhotos/Thumbnails/0602a4fa-b1d3-4fcf-9e57-e43391da642d.jpg)
The relaxation of new passport laws granted by the U.S. Department of
State and Homeland Security expires September 1, 2007.
Click here to
read more.
Other News
Jul 26, 2007
Congressman J. Randy Forbes (VA-04)
and Congressman Daniel Lipinski (IL-03) joined today in announcing the
introduction of H.R. 2807, the Patients First Act
July 20, 2007
Congressman J. Randy Forbes (VA-04) announced today that $1,500,000 has
been included for the dredging of the Appomattox River
|